USPTO serial 86911352
DONGCHENG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 28, 2017
- Examiner
- MURRAY, GEORGE WILLIAM
- Law office
- TMO LAW OFFICE 121
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DONGCHENG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
SHANDONG PROVINCE, CN
Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
SHANDONG PROVINCE, CN
Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
SHANDONG PROVINCE, CN
Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Biological herbicides; Capsules sold empty for pharmaceuticals; ] Cardiovascular pharmaceuticals; [ Chemical reagents for medical or veterinary purposes; Chondroitin preparations; ] Dietary supplements for human consumption; [ Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical products for the prevention and treatment of cancer; ] Pharmaceutical products for the treatment of joint disease [ ; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Tumor suppressing agents; Vitamin preparations ] | ACTIVE | Oct 10, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
- Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
- Other trademarks owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.
- Other trademarks in Class 005
- Similar marks named DONGCHENG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 28, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 6, 2023 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| May 6, 2023 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| May 6, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 11, 2022 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 28, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 12, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 28, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 23, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 18, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 12, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 16, 2016 | IUAF | USE AMENDMENT FILED | — |
| Dec 16, 2016 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 6, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 3, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 24, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2016 | NWAP | NEW APPLICATION ENTERED | — |